Stay Updated with the Latest Kuros Biosciences AG KURN.SW News in Real Time
Find KURN.SW news now at Meyka AI. Stay informed with the latest Kuros Biosciences AG stocks updates, including price news, market analysis, and expert insights.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.
Fluazinam Fungicide Faces EU Withdrawal Push After Brain Development Study July 12
Swedish researchers expose regulatory fraud in EU pesticide approval: fluazinam fungicide linked to brain development harm in rats, yet remains approved across Europe and Switzerland.
Anthem Biosciences Sees ₹1,275 Crore Block Deal as Societe Generale, Prudential Buy 3% Stake
Anthem Biosciences just attracted serious global institutional attention. On June 19, 2026, the Bengaluru-based pharma services company saw a large block deal hit the National Stock Exchange. Global investors led by Societe Generale, Prudential Hong Kong, and Ghisallo Capital Management acquired a combined 3% stake in Anthem Biosciences from promoter Aruna Ganesh for ₹1,275 crore…
Kuros Biosciences AG Surges 7.66% on Biotech Recovery Momentum
KURN.SW stock jumps 7.66% to CHF22.20 on SIX. Biotech recovery drives gains as orthobiologics pipeline advances.
Genocea Biosciences Stock Collapses 97% as Bankruptcy Restructuring Continues
GNCA stock plummets 97.44% to $0.0001 after Chapter 11 bankruptcy filing. Biotech firm restructures cancer immunotherapy pipeline.
AURA Director Holles Acquires 2.17M Stock Options on May 20, 2026
Aura Biosciences director Natalie Holles acquired 2.17M stock options worth $16M on May 19, 2026. Insider buying signal analyzed.
Willow Biosciences Stock Plummets 84.8% in One Day on TSX
WLLW.TO stock crashes 84.8% in single trading session. Biotech firm faces severe valuation pressure amid ongoing losses.
Idorsia Ltd (IDIA.SW) Surges 7.2% on Strong Biotech Pipeline Momentum
IDIA.SW stock rises to CHF4.58. Biotech firm advances clinical pipeline with partnerships in CNS, cardiovascular, and orphan disease treatments.
Kuros Biosciences AG Surges 8.95% on Strong Trading Volume
KURN.SW stock jumps 8.95% to CHF 20.7 on SIX with 355,006 shares traded, driven by biotech investor interest.